Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Lindner

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Oncogene|July 5, 2011
The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1CX Niu, T Zhang, L Liao, et al.
Oncogene|July 16, 2013
GRIM-19 mutations fail to inhibit v-Src-induced oncogenesisS Kalakonda, S C Nallar, D J Lindner, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 27, 2003
Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosisM Chawla-Sarkar, D J Lindner, Y-F Liu, et al.
Oncogene|July 6, 2001
Thioredoxin participates in a cell death pathway induced by interferon and retinoid combinationX Ma, S Karra, D J Lindner, et al.
The Journal of Biological Chemistry|May 2, 2001
Regulation of interferon and retinoic acid-induced cell death activation through thioredoxin reductaseX Ma, S Karra, W Guo, et al.
Oncogene|November 30, 2006
Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasionS Sengupta, K S Kim, M P Berk, et al.
Molecular and Cellular Biology|October 17, 1998
Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acidE R Hofmann, M Boyanapalli, D J Lindner, et al.
Nuclear Medicine Communications|November 26, 1999
Biodistribution of 99Tcm-labelled 5-thio-D-glucoseK Ozker, B D Collier, D J Lindner, et al.
Leukemia|January 11, 2014
Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosisA Tabarroki, D J Lindner, V Visconte, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Oncogene|July 5, 2011
The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1CX Niu, T Zhang, L Liao, et al.
Oncogene|July 16, 2013
GRIM-19 mutations fail to inhibit v-Src-induced oncogenesisS Kalakonda, S C Nallar, D J Lindner, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 27, 2003
Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosisM Chawla-Sarkar, D J Lindner, Y-F Liu, et al.
Oncogene|July 6, 2001
Thioredoxin participates in a cell death pathway induced by interferon and retinoid combinationX Ma, S Karra, D J Lindner, et al.
The Journal of Biological Chemistry|May 2, 2001
Regulation of interferon and retinoic acid-induced cell death activation through thioredoxin reductaseX Ma, S Karra, W Guo, et al.
Oncogene|November 30, 2006
Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasionS Sengupta, K S Kim, M P Berk, et al.
Molecular and Cellular Biology|October 17, 1998
Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acidE R Hofmann, M Boyanapalli, D J Lindner, et al.
Nuclear Medicine Communications|November 26, 1999
Biodistribution of 99Tcm-labelled 5-thio-D-glucoseK Ozker, B D Collier, D J Lindner, et al.
Leukemia|January 11, 2014
Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosisA Tabarroki, D J Lindner, V Visconte, et al.
Pageof 3